Corporate Profile for Daiichi Pharmaceutical, dated May 31, 1996.--(BUSINESS WIRE)--The following Corporate Profile is available for inclusion in your files. News releases for this client are distributed by Business Wire and also become part of the leading databases and information services See Information Systems. . These include Dow Jones Dow Jones the best known of several U.S. indexes of movements in price on Wall Street. [Am. Hist.: Payton, 202] See : Finance News/Retrieval, Bloomberg Financial Markets, Reuter Company Newsyear, Reuter Business Briefing, DataTimes, Nexis, Dialog, NewsNet, America OnLine See AOL. , CompuServe, Delphi, Individual's HeadsUp and First!, Desktop Data's NewsEdge, UMI UMI University Microfilms International UMI United States Minor Outlying Islands (ISO Country code) UMI University of Miami UMI Universal Management Infrastructure (IBM) Data Courier, NewsBank, Information Access Company, Prodigy, Comtex, and many others. -0- Published Date: May 31, 1996 Company Name: Daiichi Pharmaceutical Corp. Address: One Parker Plaza, Fort Lee, N.J. 07024 Main Telephone Number: 201/944-4333 Chief Executive Officer: Tsutomu Une, Ph.D., president Chief Financial Officer: Takeshi Shigihara Public Relations Contact: David Lafiosca Business number: 201/944-4333 Industry: Pharmaceutical Company description: Daiichi Pharmaceutical Corp. (abbreviated DPC DPC Department of Premier and Cabinet (Victoria, Australia) DPC Dutch Power Cows DPC Deferred Procedure Calls (Microsoft Windows NT 4. ) was established in 1982 as the solely owned U.S. subsidiary of Daiichi Pharmaceutical Co. Ltd. (Tokyo). Headquartered in Fort Lee, DPC develops select compounds from its parent company's pipeline into innovative anti-infective, anti-cancer, and wound healing wound healing Physiology The repair of a wound Steps Inflammation, repair and closure, remodeling, final healing; repair of incisions may be either simple–'clean' wounds with little loss of tissue heal by 'primary intention', or 'dirty' wounds heal by pharmaceuticals for the U.S. market. Since establishment, DPC has favorably expanded its business activities. Taxable income Under the federal tax law, gross income reduced by adjustments and allowable deductions. It is the income against which tax rates are applied to compute an individual or entity's tax liability. The essence of taxable income is the accrual of some gain, profit, or benefit to a taxpayer. of over $1 million has been sustained since the year ending March 31, 1991. In April 1995, separating its pharmaceutical and fine chemicals business operations, the company incorporated Daiichi Fine Chemicals Inc., as a 100% subsidiary located in Lincolnshire, Ill. By 1999, DPC's pharmaceutical business will show its first profitable year and the following year's retained net earnings will be upwards of $4.5 million. Time tested management principles of quality, honesty, and stability will guide DPC to achieve its goal of becoming a bona fide [Latin, In good faith.] Honest; genuine; actual; authentic; acting without the intention of defrauding. A bona fide purchaser is one who purchases property for a valuable consideration that is inducement for entering into a contract and without suspicion of being U.S. pharmaceutical company, developing and marketing innovative pharmaceuticals, continually satisfying the unmet needs of patients. CONTACT: Daiichi Pharmaceutical Corp. David Lafiosca, 201/944-4333, ext. 232 Fax: 201/944-4364 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion